Day: ខែ​កុម្ភៈ 11, 2026

Vancouver, British Columbia–(ACN Newswire via SeaPRwire.com – February 11, 2026) – Casa Minerals Inc. (TSXV: CASA) (OTCQB: CASXF) (FSE: 0CM) (the “Company” or “Casa”), is pleased to announce closing of the final tranche of its previously announced non-brokered private placement (the “Offering”). The Company has closed a total of 2,635,000 units (each, a “Unit”) at a price of $0.125 per unit for gross proceeds of up to $329,375.00 in this tranche, which would be a grand total of 7,552,000 units (each, a “Unit”) for a gross proceed of $944,000 for the announced financing.Each Unit consists of one common share of the Company (a “Share”) and one common share purchase warrant (each full warrant, a “Warrant”). Each of the 2,635,000 Warrants entitles the holder to acquire one additional share for a period of two years. The warrant exercise strike price is $0.15/share in the first three months and automatically converts to $0.20 per share then after for the remainder of the two years period.All issued Securities wil…

HONG KONG, Feb 11, 2026 – (ACN Newswire via SeaPRwire.com) – As the joint sponsor, overall coordinator, joint global coordinator, joint bookrunner and joint lead manager, Guotai Junan International Holdings Limited (“GTJAI”, stock code: 1788.HK), a company of Guotai Haitong Group, successfully assisted Axera Semiconductor Co., Ltd. (“Axera”, stock code: 600.HK) in its official listing on the Main Board of the Hong Kong Stock Exchange on February 10. This listing enriches the investment options in the Hong Kong stock market for edge AI inference system chips and demonstrates Guotai Haitong Group’s comprehensive strength in serving semiconductor technology companies.Axera is a provider of artificial intelligence (“AI”) inference systems-on-a-chip (“SoC”), delivering high-performance perception and computing platforms for edge and endpoint AI applications. It is building an advanced AI computing infrastructure to make artificial intellige…

BOSTON, Feb 11, 2026 – (ACN Newswire via SeaPRwire.com) – Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects with laboratory-confirmed acute viral infection. The Bioxyytran Trial reports complete elimination of viral load  in 100% of patients at day 7 versus placebo (p=.001).The completed Phase 2 clinical study was a randomized, double-blind, placebo-controlled, dose-optimization trial evaluating orally administered ProLectin-M in subjects with acute viral infection. The study enrolled 38 subjects, all of whom completed the study. Subjects were randomized to receive one of three ProLectin-M dose levels or a matching placebo, administered over a seven-day treatment period.Viral shedding was assessed using RT-PCR analysis of nasopharyngeal swabs collected at predefined timepoints, with viral clearance defined as non-detection of viral RNA below es…

Engagement Strengthens European Investor Outreach as Critical Minerals and Defence Partnerships AccelerateOttawa, Ontario–(ACN Newswire via SeaPRwire.com – February 11, 2026) – Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) (“Focus” or the “Company”), a leading developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce that it has engaged Dr. Reuter Investor Relations (“Dr. Reuter”) to provide investor awareness and communications services across Germany and the broader European capital markets, effective February 16, 2026.Dr. Reuter is a recognized European investor relations and financial communications firm with an established network of institutional investors, retail shareholders, and financial media throughout the DACH region and the European Union. The engagement is intended to enhance Focus Graphite’s visibility among European investors, support market education regarding its vertically integrat…

SAN DIEGO, Feb 11, 2026 – (ACN Newswire via SeaPRwire.com) – General Atomics Aeronautical Systems, Inc. (GA-ASI) was competitively selected by the U.S. Marine Corps (USMC) for evaluation in the Marine Air-Ground Task Force Uncrewed Expeditionary Tactical Aircraft (MUX TACAIR) Collaborative Combat Aircraft (CCA) program. The agreement integrates GA-ASI’s expertise in autonomy and uncrewed aircraft systems with a government-provided mission package, usingthe YFQ-42A platform as a surrogate to evaluate integration with crewed fighters.The contract initiates integration of a Marine Corps mission kit into the YFQ-42A surrogate platform for assessment within the Marine Air Ground Task Force (MAGTF).The USMC contract includes the rapid development of autonomy for the government-supplied mission kit – a cost-effective, sensor-rich, software-defined suite capable of delivering kinetic and non-kinetic effects – positioning the solution for use in expeditionary operations. This work will support evaluations of futu…